IP Library Granted Patent US 8,496,952
Granted Patent B2
US 8,496,952 · App. 12/528,557 · Granted Jul 30, 2013

Antimicrobial compositions comprising silver chloride and benzoisothiazoline

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,496,952
App. No.
12/528,557
Granted
Jul 30, 2013
Kind
B2
Abstract

The invention relates to a composition comprising a) silver and/or one or more silver compound and b) one or more biocidal active ingredients of the isothiazoline.

Claims (20)

1. A composition comprising

a) silver chloride, and

b) benzoisothiazoline or a salt thereof,

wherein the silver chloride is adsorbed on a water-insoluble, inert, nonhydratable or nonhydrated, oxidic support, and the silver chloride, calculated as elemental silver, based on the weight of the support, is present in amounts of from 0.01% by weight to 75% by weight.

2. The composition as claimed in claim 1 , wherein the water-insoluble, inert, nonhydratable or nonhydrated, oxidic support is selected from the group consisting of titanium oxide, magnesium oxide, aluminum oxide, silicon oxide, calcium oxide, barium oxide, calcium hydroxyapatite, chalk, natural ground or precipitated calcium carbonates, calcium magnesium carbonates, silicates, sheet silicates, zeolites, clays, bentonites and titanium oxide.

3. The composition as claimed in claim 1 , wherein the weight fraction of benzoisothiazoline is 0.1% to 90%.

4. The composition as claimed in claim 1 , wherein the weight fraction of silver chloride, calculated as elemental silver, is 0.01% to 50%.

5. The composition as claimed claim 1 , comprising 0.1% by weight to 90% by weight, of benzoisothiazoline and 0.01% by weight to 50% by weight of silver chloride, calculated as elemental silver.

6. The composition as claimed in claim 1 , wherein the weight ratio of constituent a), calculated as elemental silver, to constituent b) is in the range from 1:100 to 100:1.

7. The composition as claimed in claim 1 , wherein the weight ratio of constituent a), calculated as elemental silver, to constituent b) is in the range from 1:10 to 10:1.

8. The composition as claimed in claim 1 , wherein the weight ratio of constituent a), calculated as elemental silver, to constituent b), is in the range from 1:1 to 1:3.

9. The composition as claimed in claim 1 , wherein the support material has a particle size of less than 25 μm.

10. The composition as claimed in claim 1 , wherein the weight fraction of silver chloride, calculated as elemental silver, based on the weight of the support material, is in the range from 1% by weight to 50% by weight.

11. The composition as claimed in claim 1 , further comprising 0.1 to 40% by weight of polynaphthalenesulfonate, naphthalenesulfonate or alkyl sulfosuccinate.

12. The composition as claimed in claim 1 , wherein the weight fraction of benzoisothiazoline is 1% to 50%.

13. The composition as claimed in claim 1 , wherein-the weight fraction of benzoisothiazoline is 2% to 20%.

14. The composition as claimed in claim 1 , wherein the weight fraction of silver chloride, calculated as elemental silver, is 0.1% to 20%.

15. The composition as claimed in claim 1 , wherein the weight fraction of silver chloride, calculated as elemental silver, is 0.2% to 2%.

16. The composition as claimed in claim 1 , wherein the weight fraction of silver chloride, calculated as elemental silver, based on the weight of the support material, is in the range from 10% by weight to 30% by weight.

17. A process for antimicrobially treating a substrate, comprising the step of contacting the substrate with a composition as claimed in claim 1 , wherein the treated substrate comprises an amount of from 5 to 1,000 ppm of the composition as claimed in claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2015
From: CLARIANT FINANCE (BVI) LIMITED
To: CLARIANT INTERNATIONAL LTD.
Reel/Frame 036949/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2009
From: FALK, UWE; WALTER, MICHAEL MARCUS; GROHMANN, JOERG
To: CLARIANT FINANCE (BVI) LIMITED
Reel/Frame 023144/0006 →